Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$505M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$443M |
| 3 |
Alibaba
BABA
|
+$370M |
| 4 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$284M |
| 5 |
Procter & Gamble
PG
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$40M |
| 2 |
Home Depot
HD
|
+$38.9M |
| 3 |
JD.com
JD
|
+$35.3M |
| 4 |
SPDR Gold Trust
GLD
|
+$31.6M |
| 5 |
Tesla
TSLA
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 25.83% |
| 2 | Healthcare | 17.87% |
| 3 | Consumer Discretionary | 13.79% |
| 4 | Technology | 4.61% |
| 5 | Financials | 4.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Raymond James Financial
RJF
$34B
| $2.53M | 0.01% |
23,051
-13,184
| -36% | -$1.4M |
|
627
Agnico Eagle Mines
AEM
$90.5B
| $2.51M | 0.01% |
40,956
+24,879
| +155% | +$1.35M |
|
628
Usana Health Sciences
USNA
$286M
| $2.46M | 0.01% |
31,032
+6,753
| +28% | +$609K |
|
629
LPL Financial
LPLA
$28.6B
| $2.46M | 0.01% |
13,442
-1,846
| -12% | -$321K |
|
630
CryoPort
CYRX
$762M
| $2.44M | 0.01% |
69,962
+20,256
| +41% | +$766K |
|
631
Meta Platforms (Facebook)
META
$1.51T
| $2.42M | 0.01% |
10,907
+7,862
| +258% | +$1.96M |
|
632
CMS Energy
CMS
$22.3B
| $2.42M | 0.01% |
34,610
+18,472
| +114% | +$1.2M |
|
633
Leidos
LDOS
$17.3B
| $2.41M | 0.01% |
22,348
+7,697
| +53% | +$742K |
|
634
CenterPoint Energy
CNP
$26.8B
| $2.4M | 0.01% |
78,228
+43,622
| +126% | +$1.23M |
|
|
NVTA
635
DELISTED
Invitae Corporation
NVTA
| $2.4M | 0.01% |
+300,744
| New | +$3.03M |
|
636
Camden Property Trust
CPT
$11.3B
| $2.39M | 0.01% |
14,392
+9,651
| +204% | +$1.59M |
|
637
M&T Bank
MTB
$36.2B
| $2.39M | 0.01% |
14,083
-8,851
| -39% | -$1.56M |
|
638
Carter's
CRI
$1.47B
| $2.38M | 0.01% |
25,915
-17,616
| -40% | -$1.65M |
|
639
Goodyear
GT
$1.85B
| $2.38M | 0.01% |
166,738
-92,953
| -36% | -$1.65M |
|
640
Ryder
R
$10.1B
| $2.36M | 0.01% |
29,753
-21,665
| -42% | -$1.69M |
|
|
VNET
641
VNET Group
VNET
$2.09B
| $2.36M | 0.01% |
404,871
+101,129
| +33% | +$777K |
|
642
Campbell Soup
CPB
$6.87B
| $2.36M | 0.01% |
52,872
+23,422
| +80% | +$1.04M |
|
643
Darling Ingredients
DAR
$9.44B
| $2.36M | 0.01% |
29,310
+14,209
| +94% | +$990K |
|
|
MODV
644
DELISTED
ModivCare
MODV
| $2.34M | 0.01% |
20,313
+6,402
| +46% | +$739K |
|
645
Thor Industries
THO
$4.14B
| $2.34M | 0.01% |
29,790
-20,082
| -40% | -$1.85M |
|
646
Regions Financial
RF
$26.8B
| $2.34M | 0.01% |
105,132
-65,430
| -38% | -$1.54M |
|
647
Warner Bros
WBD
$67.1B
| $2.33M | 0.01% |
+93,616
| New | +$2.57M |
|
648
MSCI
MSCI
$40.9B
| $2.33M | 0.01% |
+4,627
| New | +$2.4M |
|
649
KeyCorp
KEY
$24.4B
| $2.32M | 0.01% |
103,808
-63,804
| -38% | -$1.59M |
|
650
Huntington Bancshares
HBAN
$35.5B
| $2.31M | 0.01% |
158,051
-99,532
| -39% | -$1.56M |
|
Similar funds
Ray Dalio's Q1 2022 Portfolio in Review
As of Q1 2022, Ray Dalio held 991 positions worth $24.8B, up 44% from $17.2B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ray Dalio deployed $8.89B of net new capital in Q1 2022, opening 260 new positions and adding to 547 existing holdings. Its largest new stake was Medtronic: 1,880,088 shares worth $209M.
By sector, the portfolio is most concentrated in Consumer Staples at 26% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Lowe's Companies, an estimated $40M trimmed.
- Ray Dalio's largest Q1 2022 buy was Medtronic: 1,880,088 shares worth $209M.
- Ray Dalio added most to iShares MSCI Emerging Markets ETF in Q1 2022, an estimated $505M increase.
- Ray Dalio's biggest Q1 2022 reduction was Lowe's Companies, cutting an estimated $40M.
- Ray Dalio fully exited Tesla in Q1 2022, selling an estimated $26.9M.
- Ray Dalio's ten largest holdings make up 34% of its $24.8B portfolio in Q1 2022.
- Ray Dalio opened 260 new positions and closed 23 in Q1 2022.
- Ray Dalio's portfolio value rose 44% quarter-over-quarter to $24.8B.
Based on Bridgewater Associates's 13F filing for Q1 2022, filed 13 May 2022.